March 6, 2025
TOPLINE: Among patients with KRAS G12C mutations, candidate primary resistance mutations were detected in many patients with colorectal cancer (CRC) and pancreatic ductal adenocarcinoma (PDAC), which […]
March 5, 2025
TOPLINE: Breast and colorectal cancer screening rates in 2023 surpassed pre-pandemic levels with increases of 7% and 12%, respectively, while cervical cancer screening remained 14% below […]
March 5, 2025
For patients with primary localized renal cell carcinoma (RCC), especially those who aren’t good candidates for surgery, noninvasive or minimally invasive ablative treatments have emerged as […]
March 5, 2025
TOPLINE: Bispecific antibodies (BsAbs) demonstrated a manageable safety profile in patients with non-Hodgkin lymphoma (NHL), with the prevalence of all-grade cytokine release syndrome (CRS) being 48% […]
March 5, 2025
TOPLINE: Real-world treatment patterns and outcomes among older patients with follicular lymphoma show significant heterogeneity, with 13,423 Medicare beneficiaries aged ≥ 65 years followed through 2019. […]
March 5, 2025
The US Food and Drug Administration has approved tislelizumab (Tevimbra, BeiGene), in combination with platinum-containing chemotherapy, for the first-line treatment of adults with unresectable or metastatic […]
March 4, 2025
More than a quarter of pupils are missing out on the human papillomavirus (HPV) vaccine, leaving many at risk of cancer, a new report has found. […]
March 4, 2025
TOPLINE: A default palliative care referral intervention increased palliative care consultations by more than fivefold and decreased end-of-life systemic therapy by more than half among patients […]
March 4, 2025
Tens of thousands of patients with lung cancer in the United Kingdom are missing out on targeted treatment that could improve their prognosis due to delays […]